Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Journal article
Abhishek A. et al, (2024), Lancet rheumatol, 6, e92 - e104
Enhancing Regulatory Compliance in Research Electronic Data Capture (REDCap): the MHRAFix external module (Preprint)
Preprint
Appelbe DE. et al, (2024)
Two-week break in methotrexate treatment and COVID-19 vaccine response: a prospective, open label, two-arm parallel-group, multicentre, superiority, randomised controlled trial
Journal article
Abhishek A. et al, (2023), Lancet rheumatology
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
Journal article
Williams JAE. et al, (2022), Lancet rheumatol, 4, e725 - e737
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Journal article
Abhishek A. et al, (2022), Lancet respir med, 10, 840 - 850
Two-week interruption in methotrexate treatment versus treatment continued as usual and COVID-19 booster immunity in adults with inflammatory conditions (VROOM study): a randomised open label, superiority trial
Journal article
Abhishek A. et al, (2022), The lancet respiratory medicine
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).
Journal article
Abhishek A. et al, (2022), Bmj open, 12
HAND OSTEOARTHRITIS: INVESTIGATING PAIN EFFECTS IN A RANDOMISED PLACEBO-CONTROLLED FEASIBILITY STUDY OF ESTROGEN-CONTAINING THERAPY (HOPE-E): REPORT ON THE PRIMARY FEASIBILITY OUTCOMES
Conference paper
Williams JAE. et al, (2022), Annals of the rheumatic diseases, 81, 1616 - 1617
Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.
Journal article
Shah A. et al, (2021), Br j anaesth
A Multicentre Observational Psoriatic Arthritis Cohort Study Addressing Real-life Outcomes of a Treat to Target Approach in Routine Clinical Practice.
Journal article
Coates L. et al, (2021)
Translating the Strengthening and Stretching for Rheumatoid Arthritis of the Hand Programme from clinical trial to clinical practice: An effectiveness–implementation study
Journal article
Williamson E. et al, (2020), Hand therapy, 25, 87 - 97
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis.
Journal article
Powell N. et al, (2020), Lancet gastroenterol hepatol, 5, 679 - 697
Impact evaluation of an online training on the Strengthening And Stretching for Rheumatoid Arthritis of the Hand (SARAH) programme recommended in the NICE guidelines for rheumatoid arthritis
Conference paper
Srikesavan None. et al, (2018)
A Web-Based Training Resource for Therapists to Deliver an Evidence-Based Exercise Program for Rheumatoid Arthritis of the Hand (iSARAH): Design, Development, and Usability Testing.
Journal article
Srikesavan CS. et al, (2017), J med internet res, 19
NHS implementation of the SARAH exercise programme for people with Rheumatoid arthritis via an online training programme (iSARAH)
Conference paper
Srikesavan CS. et al, (2017)
Implementation of the SARAH exercise programme for people with rheumatoid arthritis via an online training programme (iSARAH) for therapists
Journal article
Williamson E. et al, (2017), Physiotherapy, 103, e36 - e37
Impact evaluation of an online training course (iSARAH) for hand therapists: Preliminary findings
Conference paper
Srikesavan CS. et al, (2017)